Evidence map›Paper›PMID 35619128›Full record

ArticleBMC health services research2022

Process evaluation of an academic-community-government partnership to reduce liver diseases attributable to hepatitis B virus.

Daisy Le, Min Jeong Jeon, Annie Coriolan Ciceron, Y Tony Yang, Jane Pan, Hee-Soon Juon, Sherrie F Wallington

Open access · goldAbstract read
In one paragraph

Article in BMC health services research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 0 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Daisy LeThe George Washington University, School of Nursing, 1919 Pennsylvania Ave NW, Suite 500, Washington, DC, 20006, USA. daisyle@gwu.edu.
Min Jeong JeonThe George Washington University, School of Nursing, 1919 Pennsylvania Ave NW, Suite 500, Washington, DC, 20006, USA.
Annie Coriolan CiceronThe George Washington University, School of Nursing, 1919 Pennsylvania Ave NW, Suite 500, Washington, DC, 20006, USA.
Y Tony YangThe George Washington University, School of Nursing, 1919 Pennsylvania Ave NW, Suite 500, Washington, DC, 20006, USA.
Jane PanHepatitis B Initiative of Washington DC (HBI-DC), 1725 I St NW #300, Washington, DC, 20006, USA.
Hee-Soon JuonDepartment of Medical Oncology, Thomas Jefferson University, 834 Chestnut Street, Benjamin Franklin House, Suite 320, Philadelphia, PA, 19107, USA.
Sherrie F WallingtonThe George Washington University, School of Nursing, 1919 Pennsylvania Ave NW, Suite 500, Washington, DC, 20006, USA.
George Washington University · USMilken Institute · USHepatitis B Foundation · USThomas Jefferson University · US

Funding

U.S. Department of Health and Human Services Office of Minority Health 6CPIMP191177
6 · The paper itself

Abstract

backgroundRacial/ethnic minorities have higher incidence and mortality rates of liver cancer, or hepatocellular carcinoma, than non-Hispanic Whites. As such, the Washington-Baltimore Metropolitan Area Hepatitis B Virus (WB-HBV) Demonstration Project, a community-based participatory research (CBPR)-driven academic-community-government (ACG) partnership, was established in 2019 to address disparities and implement strategies to improve the HBV screening and vaccination infrastructure for at-risk communities. CBPR is a partnership of community members, organizational leaders, and academic researchers with a common aim to collectively share and contribute their input at every phase of the project. Herein, we describe the process evaluation of the WB-HBV Project and extract themes and insights to benefit future ACG partnerships and community-engaged research. The process evaluation has been conducted to determine whether CBPR-driven partnership and programmatic activities have been implemented as intended and have resulted in building expanded research capacity for future ACG partnership HBV community-level initiatives.

methodsA WB-HBV Project Task Force was convened and comprised of eight organizations: four community organizations, three government organizations, and one academic institution. Through a mixed-methods process evaluation, an online survey and key informant interviews were conducted to provide context for program implementation barriers and facilitators. Descriptive statistics were conducted, and interviews were recorded, transcribed, and thematically coded.

resultsThe survey was completed by 14 of 20 partnership members (70.0%): two academic, eight community, and four government members. Partnership members showed general agreement across 14 domains: organization and structure of meetings; trust; decisions; impact; general satisfaction; strategic planning; ACG policy impact; community-based participatory research and government; participation in meetings; assessment of participation; partnership operations and capacity; communication; challenges/limitations associated with ACG involvement; and benefits compared to challenges associated with ACG involvement. Qualitative interviews were conducted with 15 of the 20 members (75.0%): two academic, nine community, and four government members. Four themes emerged: partnership involvement, project goals and accomplishments, project challenges and barriers, and partnership involvement in government or policy.

conclusionsThe process evaluation presents insights into developing strategies to enhance partnership functioning and increase the ability of present and future ACG partnerships to improve community health outcomes.

Indexed as

Hepatitis B virusLiver DiseasesCommunity-Based Participatory ResearchCommunity-Institutional RelationsGovernmentHumansCommunity-based participatory researchCommunity health partnershipsCommunity health researchHealth disparitiesHealth outcomes

Identifiers

PMID35619128
PMCPMC9135310
OpenAlexW4281570180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.